Compounds of general formula wherein B is cyclohexyl or cyclopentyl, wherein the group R 3 and the group assume a trans configuration in relation to the ring system B; phenyl ring A has the partial structure R 2a and R 2c each independently denote C 1-6 alkoxy; R 2b is selected from among halogen and C 1-6 alkyl; or phenyl ring A has the partial structure R 2d and R 2a each independently denote C 1-6 alkoxy; R 2f is selected from among halogen and C 1-6 alkyl; R 1 denotes a group, selected from among R a, R b and R a substituted by one or more, identical or different R c and/or R b; R x denotes hydrogen; R 3 is a group, selected from among -NHS 2 R c1 and -N(C 1-4 alkyl)S 2 R c1, wherein R c1 is selected from among C 1-4 alkyl, C 3-5 cycloalkyl, C 1-4 alkoxymethyl, (C 1-4 alkyl)NH-CH 2 - and (C 1-4 alkyl) 2 N-CH 2 -; R 5 is a group, selected from among bromine, chlorine and -CF 3; n is equal to 0; each R a independently of one another is selected from among C 1-5 alkyl, C 3-10 cycloalkyl, C 4-16 cycloalkylalkyl, C 6-10 aryl, C 7-16 arylalkyl, 2-6 membered heteroalkyl, 3-8 membered heterocycloalkyl, 4-14 membered heterocycloalkylalkyl, 5-12 membered heteroaryl and 6-18 membered heteroarylalkyl; each R b is a suitable group and is selected in each case independently of one another from among =O -OR c, C 1-3 haloalkyloxy, -OCF 3, =S, -SR c, =NR c, =NOR c, =NNR c R c, =NN(R g)C NR c R c, -NR c R c, -ONR c R c, -N(OR c)R c, -N(R g)NR c R c, halogen, -CF 3, -CN, -NC, -OCN, -SCN, -NO, -NO 2, =N 2, -N 3, -S R c, -S OR c, -S 2 R c, -S 2 OR c, -S NR c R c, -S 3 NR c R c, -OS R c, -OS 2 R c, -OS 2 OR c, -OS NR c R c, -OS 2 NR c R c, -C R c, -C OR c, -C SR c, -C NR c R c, -C N(R g)NR c R c, -C N(R g)OR e, -C(NR g)NR c R c, -C R c, -C NR c R c, -OC R c, -OC OR c, -OC SR c, -OC NR c R c, -OC(NR g)NR c R c, -SC R c -SC OR c, -SC NR c R c, -SC(NR g)NR c R c, -N(R g)C R c, -N[C R c] 2, -N(OR g)C R c, -N(R g)C(NR g)R c, -N(R g)N(R g)C R c, -N[C R c]NR c R c, -N(R g)C R c, -N(R g)S R c, -N(R g)S OR c, -N(R g)S 2 R c, -N[S 2 R c] 2, -N(R g)S 2 OR c, -N(R g)S 2 NR c R c, -N(R g)[S 2] 2 R c, -N(R g)C OR c, -N(R g)C SR c, -N(R g)C NR c R c, -N(R g)C NR g NR c R c, -N(R g)N(R g)C NR c R c, -N(R g)C NR c R c, -[N(R g)C] 2 R c, -N(R g)[C] 2 R c, -N{[C] 2 R c} 2, -N(R g)[C] 2 OR c, -N(R g)[C] 2 NR c R c, -N{[C] 2 OR c} 2, -N{[C] 2 NR c R c} 2, -[N(R g)C] 2 OR c, -N(R g)C(NR g)OR c, -N(R g)C R c, -N(R g)C(NR g)SR c and -N(R g)C-(NR g)NR c R c; each R c independently of one another denotes hydrogen or a group optionally substituted by one or more, identical or different R d and/or R e, selected from among C 1-6 alkyl, C 3-10 cycloalkyl, C 4-11 cycloalkylalkyl, C 6-10 aryl, C 7-16 arylalkyl, 2-6 membered heteroalkyl, 3-8 membered heterocycloalkyl, 4-14 membered heterocycloalkylalkyl, 5-12 membered heteroaryl and 6-18 membered heteroarylalkyl; each R d denotes a suitable group and is selected in each case independently of one another from among =O, -OR e, C 1-3 haloalkyloxy, -OCF 3, =S, -SR e, =NR e, =NOR e, =NNR e R e, =NN(R g)C NR e R e, -NR e R e, -ONR e R e, -N(R g)NR e R e, halogen, -CF 3, -CN, -NC, -OCN, -SCN, -NO, -NO 2, =N 2, -N 3. -S R a, -S OR e, -S 2 R c, -S 2 OR e, -S NR e R e, -S 2 NR e R e, -OS R e, -OS 2 R e, -OS 2 OR e, -OS NR e R e, -OS 2 NR e R e, -C R e, -C OR e, -C SR e, -C NR e R e, -C N(R g)NR e R e, -C N(R g)OR e, -C(NR g)NR e R e, -C R e, -C NR e R e, -OC R e, -OC OR e, -OC SR e, -OC NR e R e, -OC(NR g)NR e R e, -SC R e, -SC OR e, -SC NR e R e, -SC(NR g)NR e R e, -N(R g)C R e, -N[C R e] 2, -N(OR g)C R e, -N(R g)C(NR g)R e, -N(R g)N(R g)C R g, -N[C R e]NR e R e, -N(R g)C R e, -N(R g)S R e, -N(R g)S OR e -N(R g)S 2 R e, -N[S 2 R e] 2, -N(R g)S 2 OR e, -N(R g)S 2 NR e R e, -N(R g)[S 2] 2 R e, -N(R g)C OR e, -N(R g)C SR e, -N(R g)C NR e R e, -N(R g)C NR g NR e R e, -N(R g)N(R g)C NR e R e, -N(R g)C NR e R e, -[N(R g)C] 2 R e, -N(R g)[C] 2 R e, -N{[C] 2 R e} 2, -N(R g)[C] 2 OR e, -N(R g)[C] 2 NR e R e, -N{[C] 2 OR e} 2, -N{[C] 2 NR e R e} 2, -[N(R g)C] 2 OR e, -N(R g)C(NR g)OR c, -N(R g)C R e, -N(R g)C(NR g)SR e and -N(R g)C(NR g)NR e R e; each R e independently of one another denotes hydrogen or a group optionally substituted by one or more, identical or different R f and/or R g selected from among C 1-6 alkyl, C 3-8 cycloalkyl, C 4-11 cycloalkylalkyl, C 6-10 aryl, C 7-16 arylalkyl, 2-6 membered heteroalkyl, 3-8 membered heterocycloalkyl, 4-14 membered heterocycloalkylalkyl, 5-12 membered heteroaryl and 6-18 membered heteroarylalkyl; each R f denotes a suitable group and is selected in each case independently of one another from among halogen, OR g and -CF 3 and each R 9 independently of one another denotes hydrogen, C 1-6 alkyl, C 3-8 cycloalkyl, C 4-11 cycloalkylalkyl, C 6-10 aryl, C 7-16 arylalkyl, 2-6 membered heteroalkyl, 3-8 membered heterocycloalkyl, 4-14 membered heterocycloalkyl, 5-12 membered heteroaryl or 6-18 membered heteroarylalkyl; with the proviso that the phenyl ring A does not simultaneously carry two chlorine substituents; optionally in the form of the tautomers, the racemates, the enantiomers, the diastereomers and the mixtures thereof, and optionally the pharmacologically acceptable acid addition salts thereof.